Beta Bionics Inc. (NASDAQ:BBNX) is one of the best hot stocks to invest in. On October 1, Goldman Sachs upgraded Beta Bionics to Buy from Neutral with a price target of $26, which was upgraded from $18. Goldman Sachs’ analysis of the diabetes technology market shows sustained growth and profitability for Beta Bionics. Earlier in the second quarter of 2025, Beta Bionics saw a significant 54% year-over-year increase in net sales, reaching $23.2 million. This growth was mirrored in patient adoption, with a 5 ...